Management of sickle cell disease: A review for physician education in Nigeria (Sub-Saharan Africa)

Anemia

Volumn 2015, Issue , 2015, Pages

  Adewoyin, Ademola Samson ^a  

^a UNIVERSITY OF BENIN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84922353169     PISSN: 20901267     EISSN: 20901275     Source Type: Journal    
DOI: 10.1155/2015/791498     Document Type: Review

References (205)

1. B. Modell, Ed., Guidelines for the Control of Haemoglobin Disorders, WHO, Sardinia, Italy, 1989.
2. G. R. Serjeant, "Sickle-cell disease, " The Lancet, vol. 350, no. 9079, pp. 725-730, 1997.
3. B. Modell and M. Darlison, "Global epidemiology of haemoglobin disorders and derived service indicators, " Bulletin of the World Health Organization, vol. 86, no. 6, pp. 480-487, 2008.
4. World Health Organisation 2008, "Management of haemoglobin disorders, " in Proceedings of the Report of Joint WHO-TIF Meeting, Nicosia, Cyprus, November 2007.
5. F. B. Piel, A. P. Patil, R. E. Howes et al., "Global epidemiology of Sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates, " The Lancet, vol. 381, no. 9861, pp. 142-151, 2013.
6. WHO Regional office for Africa, Sickle cell disease prevention and control, 2013, http://www.afro.who.int/en/nigeria/nigeriapublications/1775-sickle cell disease.html.
7. G. R. Serjeant and B. E. Serjeant, "The epidemiology of sickle cell disorder: a challenge for Africa, " Archives of Ibadan Medicine, vol. 2, no. 2, pp. 46-52, 2001.
8. A. L. Okwi, W. Byarugaba, C. M. Ndugwa, A. Parkes, M. Ocaido, and J. K. Tumwine, "An up-date on the prevalence of sickle cell trait in Eastern and Western Uganda, " BMC Blood Disorders, vol. 10, article 5, 2010.
9. A. F. Fleming, J. Storey, L. Molineaux, E. A. Iroko, and E. D. Attai, "Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival, " Annals of Tropical Medicine and Parasitology, vol. 73, no. 2, pp. 161-172, 1979.
10. P. N. Uzoegwu and A. E. Onwurah, "Prevalence of haemoglobinopathy and malaria diseases in the population of old Aguata Division, Anambra State, Nigeria, " Biokemistri, vol. 15, no. 2, pp. 57-66, 2003.
11. B. Nwogoh, A. S. Adewoyin, O. E. Iheanacho, and G. N. Bazuaye, "Prevalence of haemoglobin variants in Benin City, Nigeria, " Annals of Biomedical Sciences, vol. 11, no. 2, pp. 60-64, 2012.
12. J. A. B. Horton, The Diseases of Tropical Climates and Their Treatment, Churchill, London, UK, 1874.
13. J. B. Herrick, "Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia, " Archives of Internal Medicine, vol. 6, no. 5, pp. 517-521, 1910.
14. E. Beutler, "Disorders of haemoglobin structure: sickle cell anaemia and related abnormalities, " in Williams Haematology, M. A. Lichtman and W. J. Williams, Eds., vol. 47, pp. 667-700, McGraw-Hill, New York, NY, USA, 2006.
15. G. R. Serjeant, "The natural history of sickle cell disease, " Cold Spring Harbor Perspectives in Medicine, vol. 3, no. 10, Article ID a011783, 2013.
16. J. Pagnier, J. G. Mears, O. Dunda-Belkhodja et al., "Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa, " Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 6 I, pp. 1771-1773, 1984.
17. A. E. Kulozik, J. S. Wainscoat, G. R. Serjeant et al., "Geographical survey of β(S)-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cellmutation, " American Journal of Human Genetics, vol. 39, no. 2, pp. 239-244, 1986.
18. C. Lapoumeroulie, O. Dunda, R. Ducrocq et al., "A novel sickle gene of yet another origin in Africa: the Cameroon type, " Human Genetics, vol. 89, no. 3, pp. 333-337, 1992.
19. M. H. Steinberg, "Predicting clinical severity in sickle cell anaemia, " British Journal of Haematology, vol. 129, no. 4, pp. 465-481, 2005.
20. B. Modell, M. Darlison, H. Birgens et al., "Epidemiology of haemoglobin disorders in Europe: an overview, " Scandinavian Journal of Clinical and Laboratory Investigation, vol. 67, no. 1, pp. 39-69, 2007.
21. D. Desai and H. Dhanani, "Sickle cell disease: history and origin, " The Internet Journal of Hematology, vol. 1, no. 2, 2003.
22. A. C. Allison, "Protection afforded by sickle-cell trait against subtertianmalareal infection, " BritishMedical Journal, vol. 1, no. 4857, pp. 290-294, 1954.
23. C. Madigan and P. Malik, "Pathophysiology and therapy for haemoglobinopathies; Part I: sickle cell disease, " Expert Reviews in Molecular Medicine, vol. 8, no. 9, pp. 1-23, 2006.
24. A. Lal and E. P. Vinchinsky, "Sickle cell disease, " in Postgraduate Haematology, A. V. Hoffbrand, D. Catovsky, E. G. D. Tuddenham, and A. R. Green, Eds., vol. 7, pp. 109-125, Blackwell Publishing, 6th edition, 2011.
25. M.-H. Odièvre, E. Verger, A. C. Silva-Pinto, and J. Elion, "Pathophysiological insights in sickle cell disease, " Indian Journal of Medical Research, vol. 134, no. 10, pp. 532-537, 2011.
26. W. F. Rosse, M. Narla, L. D. Petz, and M. H. Steinberg, "New views of sickle cell disease pathophysiology and treatment, " Haematatogy, vol. 2000, no. 1, pp. 2-17, 2000.
27. M. H. Steinberg, "Management of sickle cell disease, " The New England Journal ofMedicine, vol. 340, no. 13, pp. 1021-1030, 1999.
28. P. S. Frenette, "Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion, " Microcirculation, vol. 11, no. 2, pp. 167-177, 2004.
29. J. E. Brittain and L. V. Parise, "The α4β1 integrin in sickle cell disease, " Transfusion Clinique et Biologique, vol. 15, no. 1-2, pp. 19-22, 2008.
30. J. E. Brittain, J. Han, K. I. Ataga, E. P. Orringer, and L. V. Parise, "Mechanism of CD47-induced α4β1 integrin activation and adhesion in sickle reticulocytes, "The Journal of Biological Chemistry, vol. 279, no. 41, pp. 42393-42402, 2004.
31. J. E. Elion, M. Brun, M. H. Odièvre, C. L. Lapouméroulie, and R. Krishnamoorthy, "Vaso-occlusion in sickle cell anemia: role of interactions between blood cells and endothelium, " Hematology Journal, vol. 5, no. 3, pp. S195-S198, 2004.
32. S. G. Ahmed, "The role of infection in the pathogenesis of vaso-occlusive crisis in patients with sickle cell disease, " Mediterranean Journal of Hematology and Infectious Diseases, vol. 3, no. 1, Article ID e2011028, 2011.
33. F. Fasola, K. Adedapo, J. Anetor, and M. Kuti, "Total antioxidants status and some hematological values in sickle cell disease patients in steady state, " Journal of the National Medical Association, vol. 99, no. 8, pp. 891-894, 2007.
34. M. Westerman, A. Pizzey, J. Hirschman et al., "Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy, " British Journal of Haematology, vol. 142, no. 1, pp. 126-135, 2008.
35. S. D. Roseff, "Sickle cell disease: a review, " Immunohematology, vol. 25, no. 2, pp. 67-74, 2009.
36. M. M. Hsieh, J. F. Tisdale, and G. P. Rodgers, "Haemolytic anaemia: thalassemias and sickle cell disorders, " inTheBethesda Handbook of Clinical Haematology, G. P. Rodgers and N. S. Young, Eds., vol. 4, pp. 37-56, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 3rd edition, 2013.
37. P. S. Frenette and G. F. Atweh, "Sickle cell disease: old discoveries, new concepts, and future promise, " The Journal of Clinical Investigation, vol. 117, no. 4, pp. 850-858, 2007.
38. R. P. Hebbel, R. Osarogiagbon, and D. Kaul, "The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy, " Microcirculation, vol. 11, no. 2, pp. 129-151, 2004.
39. G. J. Kato, M. T. Gladwin, and M. H. Steinberg, "Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes, " Blood Reviews, vol. 21, no. 1, pp. 37-47, 2007.
40. T. M. Walker, D. T. Dunn, and G. R. Serjeant, "The metacarpal index in homozygous sickle-cell disease, " British Journal of Radiology, vol. 61, no. 724, pp. 280-281, 1988.
41. N. C. G. Stevens, R. J. Hayes, and G. R. Serjeant, "Body shape in young children with homozygous sickle cell disease, " Pediatrics, vol. 71, no. 4, pp. 610-614, 1983.
42. F. A. Oredugba and K. O. Savage, "Anthropometric finding in Nigerian children with sickle cell disease, " Pediatric Dentistry, vol. 24, no. 4, pp. 321-325, 2002.
43. O. S. Platt, B. D. Thorington, D. J. Brambilla et al., "Pain in sickle cell disease: rates and risk factors, "The New England Journal of Medicine, vol. 325, no. 1, pp. 11-16, 1991.
44. V. Vijay, J. D. Cavenagh, and P. Yate, "The anaesthetist's role in acute sickle cell crisis, " British Journal of Anaesthesia, vol. 80, no. 6, pp. 820-828, 1998.
45. S. Delicou and K. Maragkos, "Pain management in patients with Sickle cell disease-a review, " European Medical Journal, vol. 1, pp. 30-36, 2013.
46. S. K. Ballas, "Current issues in sickle cell pain and its management, " ASH Education Book, vol. 2007, no. 1, pp. 97-105, 2007.
47. S. H. Yale, N. Nagib, and T. Guthrie, "Approach to the vasoocclusive crisis in adults with sickle cell disease, " American Family Physician, vol. 61, no. 5, pp. 1349-1356, 2000.
48. I. Okpala and A. Tawil, "Management of pain in sickle-cell disease, " Journal of the Royal Society ofMedicine, vol. 95, no. 9, pp. 456-458, 2002.
49. L. R. Solomon, "Pain management in adults with sickle cell disease in a medical center emergency department, " Journal of the National Medical Association, vol. 102, no. 11, pp. 1025-1032, 2010.
50. D. C. Rees, A. D. Olujohungbe, N. E. Parker, A. D. Stephens, P. Telfer, and J. Wright, "Guidelines for the management of the acute painful crisis in sickle cell disease, " British Journal of Haematology, vol. 120, no. 5, pp. 744-752, 2003.
51. S. C. Davies and M. Brozovic, "The presentation, management and prophylaxis of sickle cell disease, " Blood Reviews, vol. 3, no. 1, pp. 29-44, 1989.
52. A. H. Adewoye, V. Nolan, L. McMahon, Q. Ma, and M. H. Steinberg, "Effectiveness of a dedicated day hospital for management of acute sickle cell pain, " Haematologica, vol. 92, no. 6, article 854, 2007.
53. L. J. Benjamin, G. I. Swinson, and R. L. Nagel, "Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises, " Blood, vol. 95, no. 4, pp. 1130-1137, 2000.
54. M. A. Ware, I. Hambleton, I. Ochaya, and G. Serjeant, "Daycare management of sickle cell painful crisis in Jamaica: amodel applicable elsewhere?" British Journal of Haematology, vol. 104, no. 1, pp. 93-96, 1999.
55. K. L. Hassell, J. R. Eckman, and P. A. Lane, "Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes, " The American Journal of Medicine, vol. 96, no. 2, pp. 155-162, 1994.
56. T. S. Akingbola, B. Kolude, E. C. Aneni et al., "Abdominal pain in adult sickle cell disease patients: a Nigerian experience, " Annals of Ibadan PostgraduateMedicine, vol. 9, no. 2, pp. 100-104, 2011.
57. N. O. Akinola, R. A. Bolarinwa, and A. F. Faponle, "The import of abdominal pain in adults with sickle cell disorder, " West African Journal of Medicine, vol. 28, no. 2, pp. 83-86, 2009.
58. E. C. Ebert, M. Nagar, and K. D. Hagspiel, "Gastrointestinal and hepatic complications of sickle cell disease, " Clinical Gastroenterology and Hepatology, vol. 8, no. 6, pp. 483-489, 2010.
59. F. Galacteros and M. de Montalembert, "Sickle cell disease: a short guide to management, " in ESH Handbook on Disorders of Erythropoiesis, Erythrocytes and IronMetabolism, C. Beaumont, P. Beris, Y. Beuzard, and C. Brugnara, Eds., vol. 13, pp. 276-309, 2009.
60. M. E. Odunvbun and A. A. Adeyekun, "Ultrasonic assessment of the prevalence of gall stones in sickle cell disease children seen at the University of Benin Teaching Hospital, Benin City, Nigeria, " Nigerian Journal of Paediatrics, vol. 41, no. 4, pp. 370-374, 2014.
61. C. A. Agholor, A. O. Akhigbe, and O. M. Atalabi, "The prevalence of cholelithiasis in Nigerians with sickle cell disease as diagnosed by ultrasound, " British Journal of Medicine and Medical Research, vol. 4, no. 15, pp. 2866-2873, 2014.
62. National Heart and Lung and Blood Institute, TheManagement of Sickle Cell Disease, NIH Publication 02-2117, National Institutes of Health, 2002.
63. M. C. Iheanacho, A. S. Akanmu, and B. Nwogoh, "Seroprevalence of human parvovirus B19 antibody in paediatric sickle cell disease patients seen at the LagosUniversity TeachingHospital, " Annals of Biomedical Sciences, vol. 13, no. 1, pp. 123-129, 2014
64. "Genetic disorders of haemoglobin, " in Essential Haematology, A. V. Hoffbrand, P. A. H. Moss, and J. E. Pettit, Eds., vol. 6, pp. 72-93, Blackwell Publishing, Southampton, UK, 5th edition, 2006.
65. A. Akinbami, A. Dosunmu, A. Adediran et al., "Steady state hemoglobin concentration and packed cell volume in homozygous sickle cell disease patients in Lagos, Nigeria, " Caspian Journal of Internal Medicine, vol. 3, no. 2, pp. 405-409, 2012.
66. R. J. Adams, V. C. Mckie, L. H. Su et al., "Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranialDoppler ultrasonography, "The New England Journal of Medicine, vol. 339, pp. 5-11, 1998.
67. O. S. Platt, "Preventing stroke in sickle cell anemia, " The New England Journal of Medicine, vol. 353, no. 26, pp. 2743-2745, 2005.
68. R. E. Ware, S. A. Zimmerman, and W. H. Schultz, "Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease, " Blood, vol. 94, no. 9, pp. 3022-3026, 1999.
69. I. O. George and A. I. Frank-Biggs, "Stroke in Nigerian children with sickle cell anaemia, " Journal of Public Health and Epidemiology, vol. 3, no. 9, pp. 407-409, 2011.
70. O. Oniyangi, P. Ahmed, O. T. Otuneye et al., "Strokes inchildren with sickle cell disease at the NationalHospital, Abuja, Nigeria, " Nigerian Journal of Paediatrics, vol. 40, no. 2, pp. 158-164, 2013.
71. A. Ferster, P. Tahriri, C. Vermylen et al., "Five years of experience with hydroxyurea in children and young adults with sickle cell disease, " Blood, vol. 97, no. 11, pp. 3628-3632, 2001.
72. D. Powars, B. Wilson, C. Imbus, C. Pegelow, and J. Allen, "The natural history of stroke in sickle cell disease, " The American Journal of Medicine, vol. 65, no. 3, pp. 461-471, 1978.
73. I. A. Lagunju, B. J. Brown, and O. O. Sodeinde, "Chronic blood transfusion for primary and secondary stroke prevention in Nigerian children with sickle cell disease: a 5-year appraisal, " Pediatric Blood and Cancer, vol. 60, no. 12, pp. 1940-1945, 2013.
74. S. T. Miller, E. Wright, M. Abboud et al., "Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia, " The Journal of Pediatrics, vol. 139, no. 6, pp. 785-789, 2001.
75. T. L. McCavit, L. Xuan, S. Zhang, G. Flores, and C. T. Quinn, "National trends in incidence rates of hospitalization for stroke in children with sickle cell disease, " Pediatric Blood and Cancer, vol. 60, no. 5, pp. 823-827, 2013.
76. J. J. Strouse, S. Lanzkron, and V. Urrutia, "The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease, " Expert ReviewofHematology, vol. 4, no. 6, pp. 597-606, 2011.
77. W. C. Wang, "The pathophysiology, prevention, and treatment of stroke in sickle cell disease, " Current Opinion in Hematology, vol. 14, no. 3, pp. 191-197, 2007.
78. M. R. Mayberg, H. H. Batjer, R. Dacey et al., "Guidelines for the management of aneurysmal subarachnoid hemorrhage, " Stroke, vol. 25, no. 11, pp. 231-232, 1994.
79. O. S. Platt, "Prevention and management of stroke in sickle cell anemia, " Hematology, pp. 54-57, 2006.
80. M. R. DeBaun, F. D. Armstrong, R. C. McKinstry, R. E. Ware, E. Vichinsky, and F. J. Kirkham, "Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia, " Blood, vol. 119, no. 20, pp. 4587-4596, 2012.
81. M. R. DeBaun, J. Schatz, M. J. Siegel et al., "Cognitive screening examinations for silent cerebral infarcts in sickle cell disease, " Neurology, vol. 50, no. 6, pp. 1678-1682, 1998.
82. S. T. Miller, E. A. Macklin, C. H. Pegelow et al., "Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the cooperative study of sickle cell disease, " Journal of Pediatrics, vol. 139, no. 3, pp. 385-390, 2001.
83. G. O. Ogun, H. Ebili, and T. R. Kotila, "Autopsy findings and pattern ofmortality in Nigerian sickle cell disease patients, " The Pan African Medical Journal, vol. 18, article 30, 2014.
84. O. S. Platt, D. J. Brambilla, W. F. Rosse et al., "Mortality in sickle cell disease. Life expectancy and risk factors for early death, "The NewEngland Journal ofMedicine, vol. 330, no. 23, pp. 1639-1644, 1994.
85. A. Gray, E. N. Anionwu, S. C. Davies, and M. Brozovic, "Patterns of mortality in sickle cell disease in the United Kingdom, " Journal of Clinical Pathology, vol. 44, no. 6, pp. 459-463, 1991.
86. R. N. Paul, O. L. Castro, A. Aggarwal, and P. A. Oneal, "Acute chest syndrome: sickle cell disease, " European Journal of Haematology, vol. 87, no. 3, pp. 191-207, 2011.
87. P. S. Bellet, K. A. Kalinyak, R. Shukla, M. J. Gelfand, and D. L. Rucknagel, "Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases, "The New England Journal of Medicine, vol. 333, no. 11, pp. 699-703, 1995.
88. S. Charache, M. L. Terrin, R. D. Moore et al., "Effect of hydroxyurea on the frequency of painful crises in Sickle cell anemia, "The New England Journal of Medicine, vol. 332, no. 20, pp. 1317-1322, 1995.
89. A. S. Adewoyin and J. C. Obieche, "Hypertransfusion therapy in sickle cell disease in Nigeria, " Advances in Hematology, vol. 2014, Article ID923593, 8 pages, 2014.
90. G. M. Crane and N. E. Bennett, "Priapism in sickle cell anemia: emerging mechanistic understanding and better preventative strategies, " Anemia, vol. 2011, Article ID 297364, 6 pages, 2011.
91. B. Nwogoh, A. Adewoyin, G. N. Bazuaye, and I. A. Nwannadi, "Prevalence of priapism among male sickle cell disease patients at the University of Benin Teaching Hospital, Benin City, " Nigerian Medical Practitioner, vol. 65, no. 1-2, pp. 3-7, 2014.
92. E. M. Isoa, "Current trends in the management of sickle cell disease: an overview, " Benin Journal of Postgraduate Medicine, vol. 11, no. 1, pp. 50-64, 2009.
93. R. Virag, D. Bachir, K. Lee, and F. Galacteros, "Preventive treatment of priapism in sickle cell disease with oral and selfadministered intracavernous injection of etilefrine, " Urology, vol. 47, no. 5, pp. 777-781, 1996.
94. M. McDonald and R. A. Santucci, "Successful management of stuttering priapism using home self-injections of the alphaagonist metaraminol, " International Braz J Urol, vol. 30, no. 2, pp. 121-122, 2004.
95. C. Teloken, E. P. Ribeiro, M. Chammas Jr., P. E. Teloken, and C. A. V. Souto, "Intracavernosal etilefrine self-injection therapy for recurrent priapism: one decade of follow-up, " Urology, vol. 65, no. 5, p. 1002, 2005.
96. J. Cherian, A. R. Rao, A. Thwaini, F. Kapasi, I. S. Shergill, and R. Samman, "Medical and surgical management of priapism, " Postgraduate Medical Journal, vol. 82, no. 964, pp. 89-94, 2006.
97. G. J. Kato, "Priapism in sickle-cell disease: a hematologist's perspective, " The Journal of Sexual Medicine, vol. 9, no. 1, pp. 70-78, 2012.
98. A. D. Gbadoé, Y. Atakouma, K. Kusiaku, and J. K. Assimadi, "Management of sickle cell priapism with etilefrine, " Archives of Disease in Childhood, vol. 85, no. 1, pp. 52-53, 2001.
99. G. R. Serjeant, K. De Ceulaer, and G. H. Maude, "Stilboestrol and stuttering priapism in homozygous sickle-cell disease, " The Lancet, vol. 2, no. 8467, pp. 1274-1276, 1985.
100. A. L. Burnett, U. A. Anele, I. N. Trueheart, J. J. Strouss, and J. F. Casella, "Randomised Clinical Trial of sildenafil for preventing recurrent ischaemic priapism in Sickle cell disease, " American Journal of Medicine, vol. 127, no. 7, pp. 664-668, 2014.
101. A. Lane and R. Deveras, "Potential risks of chronic sildenafil use for priapism in sickle cell disease, " The Journal of Sexual Medicine, vol. 8, no. 11, pp. 3193-3195, 2011.
102. P. M. Pierorazio, T. J. Bivalacqua, and A. L. Burnett, "Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation, " Journal of Andrology, vol. 32, no. 4, pp. 371-374, 2011.
103. L. Douglas, H. Fletcher, and G. R. Serjeant, "Penile prostheses in the management of impotence in sickle cell disease, " British Journal of Urology, vol. 65, no. 5, pp. 533-535, 1990.
104. A. Mallouh and Y. Talab, "Bone and joint infection in patients with sickle cell disease, " Journal of Pediatric Orthopaedics, vol. 5, no. 2, pp. 158-162, 1985.
105. A. Almeida and I. Roberts, "Bone involvement in sickle cell disease, " British Journal of Haematology, vol. 129, no. 4, pp. 482-490, 2005.
106. W. W. Ebong, "Acute osteomyelitis in Nigerians with sickle cell disease, " Annals of the Rheumatic Diseases, vol. 45, no. 11, pp. 911-915, 1986.
107. M. Sadat-Ali, "The status of acute osteomyelitis in sickle cell disease. A 15 year review, " International Surgery, vol. 83, no. 1, pp. 84-87, 1998.
108. M. W. Burnett, J. W. Bass, and B. A. Cook, "Etiology of osteomyelitis complicating sickle cell disease, " Pediatrics, vol. 101, no. 2, pp. 296-297, 1998.
109. E. M. Barden, D. A. Kawchak, K. Ohene-Frempong, V. A. Stallings, and B. S. Zemel, "Body composition in children with sickle cell disease, "The American Journal of Clinical Nutrition, vol. 76, no. 1, pp. 218-225, 2002.
110. C. Booth, B. Inusa, and S. K. Obaro, "Infection in sickle cell disease: a review, " International Journal of Infectious Diseases, vol. 14, no. 1, pp. e2-e12, 2010.
111. F. Rahim, "The sickle cell disease, " Haematology Updates, 2010.
112. N. B. Halasa, S. M. Shankar, T. R. Talbot et al., "Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine, " Clinical Infectious Diseases, vol. 44, no. 11, pp. 1428-1433, 2007.
113. O. Akinyanju and A. O. Johnson, "Acute illness in Nigerian children with sickle cell anaemia, "Annals of Tropical Paediatrics, vol. 7, no. 3, pp. 181-186, 1987.
114. H. O. Okuonghae, M. U. Nwankwo, and E. C. Offor, "Pattern of bacteraemia in febrile children with sickle cell anaemia, " Annals of Tropical Paediatrics, vol. 13, no. 1, pp. 55-64, 1993.
115. S. Obaro, "Pneumococcal infections and sickle cell disease in Africa: does absence of evidence imply evidence of absence?" Archives of Disease in Childhood, vol. 94, no. 9, pp. 713-716, 2009.
116. J. A. Berkley, B. S. Lowe, I. Mwangi et al., "Bacteremia among children admitted to a rural hospital in Kenya, " The New England Journal of Medicine, vol. 352, no. 1, pp. 39-47, 2005.
117. A. Roca, B. Sigauque, L. Quintó et al., "Invasive pneumococcal disease in children <5 years of age in rural Mozambique, " Tropical Medicine and International Health, vol. 11, no. 9, pp. 1422-1431, 2006.
118. T. N. Williams, S. Uyoga, A. Macharia et al., "Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study, " The Lancet, vol. 374, no. 9698, pp. 1364-1370, 2009.
119. National Immunization Policy Nigeria, "National primary health care development agency 2013, " 2014.
120. P. J. Fraker, L. E. King, T. Laakko, and T. L. Vollmer, "The dynamic link between the integrity of the immune system and zinc status, " Journal of Nutrition, vol. 130, supplement 5, pp. S1399-S1406, 2000.
121. E. O. Temiye, E. S. Duke, M. A. Owolabi, and J. K. Renner, "Relationship between painful crisis and serum zinc level in children with sickle cell anaemia, " Anemia, vol. 2011, Article ID 698586, 7 pages, 2011.
122. B. O. Idonije, O. I. Iribhogbe, and G. R. A. Okogun, "Serumtrace element levels in sickle cell disease patients in an urban city in Nigeria, " Nature and Science, vol. 9, no. 3, pp. 67-71, 2011.
123. O. G. Arinola, J. A. Olaniyi, and M. O. Akiibinu, "Evaluation of antioxidant levels and trace element status in Nigerian sickle cell disease patients with Plasmodium parasitaemia, " Pakistan Journal of Nutrition, vol. 7, no. 6, pp. 766-769, 2008.
124. E. S. Klings, D. F. Wyszynski, V. G. Nolan, and M. H. Steinberg, "Abnormal pulmonary function in adults with sickle cell anemia, " American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 11, pp. 1264-1269, 2006.
125. A. O. Dosunmu, T. M. Balogun, O. O. Adeyeye et al., "Prevalence of pulmonary hypertension in sickle cell anaemia patients of a tertiary hospital in Nigeria, " Nigerian Medical Journal, vol. 55, no. 2, pp. 161-165, 2014.
126. A. O. Dosunmu, R. A. Akinola, J. A. Onakoya et al., "Pattern of chronic lung lesions in adults with sickle cell disease in Lagos, Nigeria, " Caspian Journal of Internal Medicine, vol. 4, no. 4, pp. 754-758, 2013.
127. A. E. Fawibe, "Sickle cell chronic pulmonary disease among Africans: the need for increased recognition and treatment, " African Journal of Respiratory Medicine, pp. 13-16, 2008.
128. M. T. Gladwin, V. Sachdev, M. L. Jison et al., "Pulmonary hypertension as a risk factor for death in patients with sickle cell disease, " The New England Journal of Medicine, vol. 350, no. 9, pp. 886-895, 2004.
129. H. Issa and A. H. Al-Salem, "Hepatobiliary manifestations of sickle cell anemia, " Gastroenterology Research, vol. 3, no. 1, pp. 1-8, 2010.
130. F. A. Fashola and I. A. Otegbayo, "Post transfusion viral hepatitis in sickle cell anaemia: retrospective-prospective analysis, " Nigerian Journal of Clinical Practice, vol. 5, no. 1, pp. 16-19, 2002.
131. E. U. Ejeliogu, S. N. Okolo, S. D. Pam, E. S. Okpe, C. C. John, and M. O. Ochoga, "Is human immunodeficiency virus still transmissible through blood transfusion in children with sickle cell anaemia in Jos, Nigeria?" The British Journal of Medicine and Medical Research, vol. 4, no. 21, pp. 3912-3923, 2014.
132. G. O. Ogunrinde, R. O. Zubair, S. M. Mado, S. Musa, and L. W. Umar, "Prevalence of nocturnal enuresis in children with homozygous sickle cell disease in zaria, " Nigerian Journal of Paediatrics, vol. 34, pp. 31-35, 2007.
133. A. Abdu, M. Emokpae, P. Uadia, and A. Kuliya-Gwarzo, "Proteinuria among adult sickle cell anemia patients in Nigeria, " Annals of African Medicine, vol. 10, no. 1, pp. 34-37, 2011.
134. J. C. Aneke, A. O. Adegoke, A. A. Oyekunle et al., "Degrees of kidney disease in Nigerian adults with sickle-cell disease, " Medical Principles and Practice, vol. 23, no. 3, pp. 271-274, 2014.
135. C. C. Sharpe and S. L. Thein, "HowI treat renal complications in sickle cell disease, " Blood, vol. 123, no. 24, pp. 3720-3726, 2014.
136. K. I. Ataga and E. P. Orringer, "Renal abnormalities in sickle cell disease, " American Journal of Hematology, vol. 63, pp. 205-211, 2000.
137. P. I. Condon and G. R. Serjeant, "Ocular findings in homozygous sickle cell anemia in Jamaica, " The American Journal of Ophthalmology, vol. 73, no. 4, pp. 533-543, 1972.
138. M. Koshy, R. Entsuah, A. Koranda et al., "Leg ulcers in patients with sickle cell disease, " Blood, vol. 74, no. 4, pp. 1403-1408, 1989.
139. G. N. Bazuaye, A. I. Nwannadi, and E. E. Olayemi, "LegUlcers in Adult sickle cell disease patients in Benin City, Nigeria, " Gomal Journal of Medical Sciences, vol. 8, no. 2, pp. 190-194, 2010.
140. R. A. Balogun, D. C. Obalum, S. O. Giwa, T. O. Adekoya-Cole, C. N. Ogo, and G. O. Enweluzo, "Spectrumof musculo-skeletal disorders in sickle cell disease in Lagos, Nigeria, " Journal of Orthopaedic Surgery and Research, vol. 5, article 2, 2010.
141. P. Hernigou, A. Habibi, D. Bachir, and F. Galacteros, "The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease, " Journal of Bone and Joint Surgery-Series A, vol. 88, no. 12, pp. 2565-2572, 2006.
142. A. J. Madu, A. K. Madu, G. K. Umar, K. Ibekwe, A. Duru, and A. O. Ugwu, "Avascular necrosis in sickle cell (homozygous S) patients: predictive clinical and laboratory indices, " Nigerian Journal of Clinical Practice, vol. 17, no. 1, pp. 86-89, 2014.
143. H. Hawker, H. Neilson, R. J. Hayes, and G. R. Serjeant, "Haematological factors associated with avascular necrosis of the femoral head in homozygous sickle cell disease, " British Journal of Haematology, vol. 50, no. 1, pp. 29-34, 1982.
144. M. Mukisi-Mukaza, A. Elbaz, Y. Samuel-Leborgne et al., "Prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adults with sickle cell disease, " Orthopedics, vol. 23, no. 4, pp. 357-363, 2000.
145. A. D. Adekile, R. Gupta, F. Yacoub, T. Sinan, M. Al-Bloushi, and M. Z. Haider, "Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of α-thalassemia trait, " Acta Haematologica, vol. 105, no. 1, pp. 27-31, 2001
146. "Sickle cell disease in childhood. Standards and guidelines for clinical care, " UK Forum on Haemoglobin Disorders, 2010.
147. M. T. Gladwin and V. Sachdev, "Cardiovascular abnormalities in sickle cell disease, " Journal of theAmericanCollege of Cardiology, vol. 59, no. 13, pp. 1123-1133, 2012.
148. N. I. Oguanobi, E. C. Ejim, B. C. Anisiuba et al., "Clinical and electrocardiographic evaluation of sickle-cell anaemia patients with pulmonary hypertension, " ISRN Hematology, vol. 2012, Article ID 768718, 6 pages, 2012.
149. B. Otaigbe, "Prevalence of blood transfusion in sickle cell anaemia patients in South-South Nigeria: a two-year experience, " International Journal of Biological and Medical Research, vol. 1, no. 1, pp. 13-18, 2013.
150. H. H. Al-Saeed and A. H. Al-Salem, "Principles of blood transfusion in sickle cell anemia, " SaudiMedical Journal, vol. 23, no. 12, pp. 1443-1448, 2002.
151. Z. Y. Aliyu, A. R. Tumblin, and G. J. Kato, "Current therapy of sickle cell disease, " Haematologica, vol. 91, no. 1, pp. 7-11, 2006.
152. N. Win, "Blood transfusion therapy for Haemoglobinopathies, " in Practical Management of Haemoglobinopathies, I. E. Okpala, Ed., pp. 99-106, Blackwell Publishing, 2004.
153. C. D. Josephson, L. L. Su, K. L. Hillyer, and C. D. Hillyer, "Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines, " Transfusion Medicine Reviews, vol. 21, no. 2, pp. 118-133, 2007.
154. E. P. Vinchinsky, "Transfusion therapy in sickle cell disease, " 2014, http://sickle.bwh.harvard.edu/transfusion.html.
155. J. L. Levenson, "Psychiatric issues in adults with sickle cell disease, " Primary Psychiatry, vol. 15, no. 5, pp. 45-49, 2008.
156. K. A. Anie, F. E. Egunjobi, and O. O. Akinyanju, "Psychosocial impact of sickle cell disorder: perspectives from a Nigerian setting, " Globalization and Health, vol. 6, article 2, 2010.
157. C. Hilton, M. Osborn, S. Knight, A. Singhal, and G. Serjeant, "Psychiatric complications of homozygous sickle cell disease among young adults in the Jamaican cohort study, " The British Journal of Psychiatry, vol. 170, pp. 69-76, 1997.
158. V. J. Rappaport, M. Velazquez, and K. Williams, "Hemoglobinopathies in pregnancy, " Obstetrics and Gynecology Clinics of North America, vol. 31, no. 2, pp. 287-317, 2004.
159. R. P. Naik and S. Lanzkron, "Baby on board: what you need to know about pregnancy in the hemoglobinopathies, " Hematology, vol. 2012, pp. 208-214, 2012.
160. B. B. Afolabi, N. C. Iwuala, I. C. Iwuala, and O. K. Ogedengbe, "Morbidity and mortality in sickle cell pregnancies in Lagos, Nigeria: a case control study, " Journal of Obstetrics and Gynaecology, vol. 29, no. 2, pp. 104-106, 2009.
161. A. Omole-Ohonsi, O. A. Ashimi, and T. A. Aiyedun, "Preconception care and sickle cell anemia in pregnancy, " Journal of Basic and Clinical Reproductive Sciences, vol. 1, no. 1, pp. 12-18, 2012.
162. Z. M. Al-Samak, M. M. Al-Falaki, and A. A. Pasha, "Assessment of perioperative transfusion therapy and complications in sickle cell disease patients undergoing surgery, "Middle East Journal of Anesthesiology, vol. 19, no. 5, pp. 983-995, 2008.
163. W. A. Marchant and I. Walker, "Anaesthetic management of the childwith sickle cell disease, " Paediatric Anaesthesia, vol. 13, no. 6, pp. 473-489, 2003.
164. E. P. Vichinsky, C. M. Haberkern, L. Neumayr et al., "A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease, " The New England Journal of Medicine, vol. 333, no. 4, pp. 206-213, 1995.
165. H. M. Dix, "New advances in the treatment of sickle cell disease: focus on perioperative significance, " Journal of the American Association of Nurse Anesthetists, vol. 69, no. 4, pp. 281-286, 2001.
166. P. Losco, G. Nash, P. Stone, and J. Ventre, "Comparison of the effects of radiographic contrast media on dehydration and filterability of red blood cells from donors homozygous for hemoglobin A or hemoglobin S, " American Journal of Hematology, vol. 68, no. 3, pp. 149-158, 2001.
167. T. R. Kotila, "Guidelines for the diagnosis of the haemoglobinopathies in Nigeria, " Annals of Ibadan Postgraduate Medicine, vol. 8, no. 1, pp. 25-29, 2011.
168. Y. Daniel, "Haemoglobinopathy diagnostic tests: blood counts, sickle solubility test, haemoglobin electrophoresis and highperformance liquid chromatography, " in Practical Management of Haemoglobinopathies, I. E. Okpala, Ed., pp. 10-19, Blackwell Publishing, 2004.
169. B. J. Bain, "Haemoglobinopathy diagnosis: algorithms, lessons and pitfalls, " Blood Reviews, vol. 25, no. 5, pp. 205-213, 2011.
170. G. M. Clarke and T. N. Higgins, "Laboratory investigation of hemoglobinopathies and thalassemias: review and update, " Clinical Chemistry, vol. 46, no. 8, part 2, pp. 1284-1290, 2000.
171. O. Emmanuelchide, O. Charle, and O. Uchenna, "Hematological parameters in association with outcomes in sickle cell anemia patients, " Indian Journal ofMedical Sciences, vol. 65, no. 9, pp. 393-398, 2011.
172. S. A. Adegoke and B. P. Kuti, "Evaluation of clinical severity of sickle cell anaemia in Nigerian children, " Journal of Applied Hematology, vol. 4, no. 2, pp. 58-64, 2013.
173. C. T. Quinn, Z. R. Rogers, and G. R. Buchanan, "Survival of children with sickle cell disease, " Blood, vol. 103, no. 11, pp. 4023-4027, 2004.
174. K. J. J. Wierenga, I. R. Hambleton, and N. A. Lewis, "Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study, " The Lancet, vol. 357, no. 9257, pp. 680-683, 2001.
175. A. Chijioke and P. M. Kolo, "The longevity and clinical pattern of adult sickle cell anaemia in Ilorin, " European Journal of Scientific Research, vol. 32, no. 4, pp. 528-532, 2009.
176. M. Angastiniotis, S. Kyriakidou, and M. Hadjiminas, "How thalassaemia was controlled in Cyprus., " World Health Forum, vol. 7, no. 3, pp. 291-297, 1986.
177. M. A. Durosinmi, A. I. Odebiyi, I. A. Adediran, N. O. Akinola, D. E. Adegorioye, and M. A. Okunade, "Acceptability of prenatal diagnosis of sickle cell anaemia (SCA) by female patients and parents of SCA patients inNigeria, " Social Science andMedicine, vol. 41, no. 3, pp. 433-436, 1995.
178. A. S. Adeyemi and D. A. Adekanle, "Knowledge and attitude of female health workers towards prenatal diagnosis of sickle cell disease, " Nigerian Journal ofMedicine, vol. 16, no. 3, pp. 268-270, 2007.
179. M. B. Kagu, U. A. Abjah, and S. G. Ahmed, "Awareness and acceptability of prenatal diagnosis of sickle cell anaemia among health professionals and students in North Eastern Nigeria, " Nigerian Journal of Medicine, vol. 13, no. 1, pp. 48-51, 2004.
180. World Health Organisation, Guidelines for the Control of Haemoglobin Disorders, WHO, Sardinia, Italy, 1994.
181. S. O. Akodu, I. N. Diaku-Akinwumi, and O. F. Njokanma, "Age at diagnosis of sickle cell anaemia in lagos, Nigeria, " Mediterranean Journal of Hematology and Infectious Diseases, vol. 5, no. 1, Article ID e2013001, 2013.
182. F. A. Olatona, K. A. Odeyemi, A. T. Onajole, and M. C. Asuzu, "Effects of health education on knowledge and attitude of youth corps members to sickle cell disease and its screening in Lagos State, " Journal of CommunityMedicine and Health Education, vol. 2, article 163, 2012.
183. N. Galadanci, B. J. Wudil, T. M. Balogun et al., "Current sickle cell disease management practices in Nigeria, " International Health, vol. 6, no. 1, pp. 23-28, 2014.
184. A. A. Oyekunle, "Haemopoietic stem cell transplantation: prospects and challenges inNigeria, "Annals of Ibadan Postgraduate Medicine, vol. 4, no. 1, pp. 17-27, 2006.
185. N. Bazuaye, B. Nwogoh, D. Ikponmwen et al., "First successful allogeneic hematopoietic stem cell transplantation for a sickle cell disease patient in a low resource country (Nigeria): a case report, " Annals of Transplantation, vol. 19, no. 1, pp. 210-213, 2014.
186. O. O. Akinyanju, A. I. Otaigbe, and M. O. O. Ibidapo, "Outcome of holistic care in Nigerian patients with sickle cell anaemia, " Clinical and Laboratory Haematology, vol. 27, no. 3, pp. 195-199, 2005.
187. I. E. Okpala, "Sickle cell crisis, " in PracticalManagement of Haemoglobinopathies, I. E. Okpala, Ed., pp. 63-71, Blackwell Publishing, 2004.
188. I. Okpala, V. Thomas, N. Westerdale et al., "The comprehensive care of sickle cell disease, " European Journal ofHaematology, vol. 68, no. 3, pp. 157-162, 2002.
189. J. Makani, S. F. Ofori-Acquah, O. Nnodu, A. Wonkam, and K. Ohene-Frempong, "Sickle cell disease: new opportunities and challenges in Africa, " The Scientific World Journal, vol. 2013, Article ID 193252, 16 pages, 2013.
190. O. Oniyangi and A. A. A. Omari, "Malaria chemoprophylaxis in sickle cell disease, " The Cochrane Library, vol. 1, pp. 1-18, 2009.
191. E. O. Ibe, A. C. J. Ezeoke, I. Emeodi et al., "Electrolyteprofile and prevalent causes of sickle cell crisis in Enugu, Nigeria, " African Journal of Biochemistry Research, vol. 3, no. 11, pp. 370-374, 2009.
192. R. A. Bolarinwa, N. O. Akinola, O. A. Aboderin, and M. A. Durosinmi, "Therole of malaria in vaso-occlusive crisis of adult patients with sickle cell disease, " Journal of Medicine and Medical Sciences, vol. 1, pp. 407-411, 2010.
193. R. Kotila, A. Okesola, and O. Makanjuola, "Asymptomatic malaria parasitaemia in sickle-cell disease patients: how effective is chemoprophylaxis?" Journal of Vector BorneDiseases, vol. 44, no. 1, pp. 52-55, 2007.
194. R. E. Ware, "How I use hydroxyurea to treat young patients with sickle cell anemia, " Blood, vol. 115, no. 26, pp. 5300-5311, 2010.
195. S. C. Davies and A. Gilmore, "The role of hydroxyurea in the management of sickle cell disease, " Blood Reviews, vol. 17, no. 2, pp. 99-109, 2003.
196. S. C. Davies and I. A. G. Roberts, "Bone marrow transplant for sickle cell disease-an update, " Archives ofDisease in Childhood, vol. 75, no. 1, pp. 3-6, 1996.
197. I. Roberts, "Current status of allogeneic transplantation for haemoglobinopathies, " British Journal of Haematology, vol. 98, no. 1, pp. 1-7, 1997.
198. S. Shenoy, "Hematopoietic stem cell transplantation for sickle cell disease: current practice and emerging trends, " Hematology, vol. 2011, pp. 273-279, 2011.
199. L. De Franceschi, "Pathophysiology of sickle cell disease and new drugs for the treatment, " Mediterranean Journal of Hematology and Infectious Diseases, vol. 1, no. 1, 2009.
200. L. De Franceschi and R. Corrocher, "Established and experimental treatments for sickle cell disease, " Haematologica, vol. 89, no. 3, pp. 348-356, 2004.
201. K. I. Ataga and J. Stocker, "Senicapoc (ICA17043): a potential therapy for the prevention and treatment of hemolysisassociated complications in sickle cell anemia, " Expert Opinion on Investigational Drugs, vol. 18, no. 2, pp. 231-239, 2009.
202. K. I. Ataga, W. R. Smith, L. M. De Castro et al., "Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia, " Blood, vol. 111, no. 8, pp. 3991-3997, 2008.
203. I. E. Okpala, "New therapies for sickle cell disease, " Hematology/Oncology Clinics of North America, vol. 19, no. 5, pp. 975-987, 2005.
204. M. J. Stuart and R. L. Nagel, "Sickle-cell disease, "TheLancet, vol. 364, no. 9442, pp. 1343-1360, 2004.
205. M. C. Walters, "Stem cell therapy for sickle cell disease: transplantation and gene therapy, " Hematology, vol. 2005, no. 1, pp. 66-73, 2005.